Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 5, 2012, Pages

  White, Elizabeth A ^a   Sowa, Mathew E ^a   Tan, Min Jie Alvin ^a   Jeudy, Sheila ^a   Hayes, Sebastian D ^a   Santha, Sreevidya ^a   Mun̈ger, Karl ^b   Harper, J Wade ^a   Howley, Peter M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cervical cancer; Keratinocyte; Proteomics; Retinoblastoma protein; Ubiquitylation

Indexed keywords

CELL PROTEIN; CULLIN; ONCOPROTEIN; PROTEIN E7; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE; VIRUS DNA;

ARTICLE; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; KERATINOCYTE; MASS SPECTROMETRY; NONHUMAN; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; UBIQUITINATION; UTERINE CERVIX CANCER; VIRUS CELL INTERACTION; VIRUS TYPING; WART VIRUS;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL LINE; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; TANDEM MASS SPECTROMETRY;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 84857128437     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1116776109     Document Type: Article

References (50)

1. Bernard HU, et al. (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-79.
2. Howley PM, Lowy DR (2006) Papillomaviruses. Fields Virology, eds Knipe DM, et al. (Lippincott Williams and Wilkins, Philadelphia), 5th Ed.
3. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108. (Pubitemid 40372904)
4. Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M (2008) Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer 113(7 suppl):1980-1993.
5. Dyson N, Guida P, Münger K, Harlow E (1992) Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 66:6893-6902.
6. Dyson N, Howley PM, Münger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937. (Pubitemid 19066153)
7. Münger K, et al. (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8:4099-4105. (Pubitemid 20066852)
8. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505. (Pubitemid 23335075)
9. Werness BA, Levine AJ, Howley PM (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
10. Jablonska S, Orth G (1985) Epidermodysplasia verruciformis. Clin Dermatol 3:83-96.
11. Pfister H (2003) Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31:52-56.
12. Akgül B, Cooke JC, Storey A (2006) HPV-associated skin disease. J Pathol 208:165-175. (Pubitemid 43126110)
13. Feltkamp MC, de Koning MN, Bavinck JN, Ter Schegget J (2008) Betapapillomaviruses: Innocent bystanders or causes of skin cancer. J Clin Virol 43:353-360.
14. Behrends C, Sowa ME, Gygi SP, Harper JW (2010) Network organization of the human autophagy system. Nature 466:68-76.
15. Sowa ME, Bennett EJ, Gygi SP, Harper JW (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138:389-403.
16. Svendsen JM, et al. (2009) Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell 138:63-77.
17. O'Connell BC, et al. (2010) A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L-NFKBIL2 complex required for genomic stability. Mol Cell 40: 645-657.
18. Powell ML, et al. (2010) NCoR1 mediates papillomavirus E8;E2C transcriptional repression. J Virol 84:4451-4460.
19. Dickson MA, et al. (2000) Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20:1436-1447. (Pubitemid 30069263)
20. Bennett EJ, Rush J, Gygi SP, Harper JW (2010) Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. Cell 143:951-965.
21. Rahman S, et al. (2011) The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol 31:2641-2652.
22. Lee PC, Sowa ME, Gygi SP, Harper JW (2011) Alternative ubiquitin activation/ conjugation cascades interact with N-end rule ubiquitin ligases to control degradation of RGS proteins. Mol Cell 43:392-405.
23. Litterman N, et al. (2011) An OBSL1-Cul7Fbxw8 ubiquitin ligase signaling mechanism regulates Golgi morphology and dendrite patterning. PLoS Biol 9:e1001060.
24. Tan MK, Lim HJ, Harper JW (2011) SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation. Mol Cell Biol 31:3687-3699.
25. DeMasi J, Huh KW, Nakatani Y, Münger K, Howley PM (2005) Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding. Proc Natl Acad Sci USA 102:11486-11491. (Pubitemid 41153846)
26. Huh KW, et al. (2005) Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc Natl Acad Sci USA 102:11492-11497.
27. Jang JH (2004) FIGC, a novel FGF-induced ubiquitin-protein ligase in gastric cancers. FEBS Lett 578:21-25.
28. Kim TA, et al. (1998) NRP/B, a novel nuclear matrix protein, associates with p110(RB) and is involved in neuronal differentiation. J Cell Biol 141:553-566.
29. Mahrour N, et al. (2008) Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases. J Biol Chem 283:8005-8013.
30. Vasudevan S, Starostina NG, Kipreos ET (2007) The Caenorhabditis elegans cell-cycle regulator ZYG-11 defines a conserved family of CUL-2 complex components. EMBO Rep 8:279-286. (Pubitemid 46344594)
31. Huh K, et al. (2007) Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol 81:9737-9747. (Pubitemid 350067678)
32. Soucy TA, et al. (2009) An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458:732-736.
33. Wolff T, O'Neill RE, Palese P (1998) NS1-Binding protein (NS1-BP): A novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. J Virol 72:7170-7180. (Pubitemid 28377846)
34. Imai Y, Matsushima Y, Sugimura T, Terada M (1991) Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product. J Virol 65:4966-4972.
35. Boyer SN, Wazer DE, Band V (1996) E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56:4620-4624. (Pubitemid 26338060)
36. Jones DL, Thompson DA, Münger K (1997) Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology 239:97-107. (Pubitemid 28027074)
37. Cockman ME, et al. (2000) Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275:25733-25741.
38. Ivan M, et al. (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292:464-468. (Pubitemid 32335941)
39. Maxwell PH, et al. (1999) The tumour suppressor protein VHL targets hypoxiainducible factors for oxygen-dependent proteolysis. Nature 399:271-275. (Pubitemid 29246458)
40. McLaughlin-Drubin ME, Münger K (2009) The human papillomavirus E7 oncoprotein. Virology 384:335-344.
41. Petroski MD, Deshaies RJ (2005) Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6:9-20. (Pubitemid 40064895)
42. Kamura T, et al. (2004) VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev 18:3055-3065. (Pubitemid 39658174)
43. Perez-Torrado R, Yamada D, Defossez PA (2006) Born to bind: The BTB proteinprotein interaction domain. Bioessays 28:1194-1202. (Pubitemid 44925439)
44. Berezutskaya E, Yu B, Morozov A, Raychaudhuri P, Bagchi S (1997) Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein. Cell Growth Differ 8:1277-1286. (Pubitemid 28008724)
45. Gonzalez SL, Stremlau M, He X, Basile JR, Münger K (2001) Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J Virol 75:7583-7591. (Pubitemid 32738016)
46. Barry M, Früh K (2006) Viral modulators of cullin RING ubiquitin ligases: culling the host defense. Sci STKE 2006:pe21.
47. Lamesch P, et al. (2007) hORFeome v3.1: A resource of human open reading frames representing over 10,000 human genes. Genomics 89:307-315. (Pubitemid 46210126)
48. Smith JA, et al. (2010) Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc Natl Acad Sci USA 107:3752-3757.
49. Shannon P, et al. (2003) Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498-2504. (Pubitemid 37428274)
50. Nakatani Y, et al. (2005) p600, a unique protein required for membrane morphogenesis and cell survival. Proc Natl Acad Sci USA 102:15093-15098. (Pubitemid 41513340)